 |
Regence’s coverage policy developed to encourage generic alendronate (Fosamax®) is an excellent opportunity to reduce patients’ copayments…Learn more >

NHLBI Guidelines and clinical studies suggest that Advair® and Symbicort® should be reserved for patients not adequately controlled on ICS products…Learn more >

|
 |
MDeNews June 2008
Avastin® Approved for use in Metastatic Breast Cancer – The Controversial FDA Decision...Learn
more>


Use our RxPrice
Guide to get more information about a specific medication.
 |
 |